Pharmagreen Biotech Statistics
Total Valuation
PHBI has a market cap or net worth of 995,469. The enterprise value is 1.30 million.
| Market Cap | 995,469 |
| Enterprise Value | 1.30M |
Important Dates
The next estimated earnings date is Friday, May 16, 2025.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PHBI has 663.65 million shares outstanding. The number of shares has increased by 28.47% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 663.65M |
| Shares Change (YoY) | +28.47% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 10.55% |
| Owned by Institutions (%) | n/a |
| Float | 588.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 331.60 |
| PB Ratio | -0.42 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.75 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.04
| Current Ratio | 0.04 |
| Quick Ratio | 0.00 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.09 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -139.13% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 10.15% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.20 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +89.19% in the last 52 weeks. The beta is 1.45, so PHBI's price volatility has been higher than the market average.
| Beta (5Y) | 1.45 |
| 52-Week Price Change | +89.19% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Relative Strength Index (RSI) | 53.61 |
| Average Volume (20 Days) | 1,082,627 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.01 |
Income Statement
In the last 12 months, PHBI had revenue of 3,002 and -226,257 in losses. Loss per share was -0.00.
| Revenue | 3,002 |
| Gross Profit | 1,348 |
| Operating Income | -234,387 |
| Pretax Income | -226,292 |
| Net Income | -226,257 |
| EBITDA | n/a |
| EBIT | -234,387 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 906 in cash and 352,411 in debt, giving a net cash position of -351,505 or -0.00 per share.
| Cash & Cash Equivalents | 906 |
| Total Debt | 352,411 |
| Net Cash | -351,505 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -2.40M |
| Book Value Per Share | -0.00 |
| Working Capital | -2.31M |
Cash Flow
| Operating Cash Flow | -32,981 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 44.90% |
| Operating Margin | -7,807.69% |
| Pretax Margin | -7,538.04% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PHBI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.47% |
| Shareholder Yield | -28.47% |
| Earnings Yield | -22.73% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
PHBI has an Altman Z-Score of -228.61. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -228.61 |
| Piotroski F-Score | n/a |